MedPath

CEO-TWO BOWEL EVACUANT SUPPOSITORIES

CEO-TWO BOWEL EVACUANT SUPPOSITORIES

Discontinued
DIN Number

02090074

Drug Class

Human

Market Date

Apr 7, 2000

Company
HC

beutlich l.p.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02090074
AIG Number0214985001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AD10 MINERAL SALTS IN COMBINATION
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

POTASSIUM BITARTRATEActive
Strength: 942 MG
Monograph: POTASSIUM BITARTRATE
SODIUM BICARBONATEActive
Strength: 627 MG
Monograph: SODIUM BICARBONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.